Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
Completed
- Conditions
- COVIDSARS-CoV 2
- Interventions
- Diagnostic Test: Serological testDiagnostic Test: Nasopharyngeal SwabDiagnostic Test: Oropharyngeal Swab
- Registration Number
- NCT04408014
- Lead Sponsor
- Butantan Institute
- Brief Summary
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
- Detailed Description
This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18901
Inclusion Criteria
- All potential volunteers invited to participate in the study.
Exclusion Criteria
- All potential eligible participants, but who do not show interest in participating in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CPP - Butantan Penitentiary Progression Center Oropharyngeal Swab Participants of the CPP - Butantan Penitentiary Progression Center CHSP - Penitentiary System Hospital Center Oropharyngeal Swab Participants of the CHSP - Penitentiary System Hospital Center SABE (Health, Wellness and Aging) Serological test Participants of the SABE Project (Health, Wellness and Aging) ILPI - Long-Term Care Institution for the Elderly Nasopharyngeal Swab Residents of the Long-Term Care Institution for the Elderly of Botucatu ILPI - Long-Term Care Institution for the Elderly Oropharyngeal Swab Residents of the Long-Term Care Institution for the Elderly of Botucatu HC-USP Nasopharyngeal Swab Home contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo CPP - Butantan Penitentiary Progression Center Serological test Participants of the CPP - Butantan Penitentiary Progression Center CORAS Serological test Refugees living in the city of São Paulo CORAS Oropharyngeal Swab Refugees living in the city of São Paulo CPP - Butantan Penitentiary Progression Center Nasopharyngeal Swab Participants of the CPP - Butantan Penitentiary Progression Center CHSP - Penitentiary System Hospital Center Serological test Participants of the CHSP - Penitentiary System Hospital Center SABE (Health, Wellness and Aging) Nasopharyngeal Swab Participants of the SABE Project (Health, Wellness and Aging) ICR-USP - Children's Institute of HCFMUSP Nasopharyngeal Swab Home contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP HC-USP Oropharyngeal Swab Home contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo Hemocenter Serological test Blood Donors of the Pró-Sangue Hemocenter Foundation of São Paulo CORAS Nasopharyngeal Swab Refugees living in the city of São Paulo CHSP - Penitentiary System Hospital Center Nasopharyngeal Swab Participants of the CHSP - Penitentiary System Hospital Center ILPI - Long-Term Care Institution for the Elderly Serological test Residents of the Long-Term Care Institution for the Elderly of Botucatu ICR-USP - Children's Institute of HCFMUSP Serological test Home contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP HC-USP Serological test Home contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo SABE (Health, Wellness and Aging) Oropharyngeal Swab Participants of the SABE Project (Health, Wellness and Aging) ICR-USP - Children's Institute of HCFMUSP Oropharyngeal Swab Home contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
- Primary Outcome Measures
Name Time Method Prevalence of antibodies against SARS-CoV-2 through serological testing 1 month IgM and IgG antibodies against SARS-CoV-2
Frequency of participants with a positive RT-PCR test result for SARS-CoV-2 1 month Positive RT-PCR test result for SARS-CoV-2
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Avenida Vital Brasil 1500
🇧🇷Sao Paulo, Brazil